News
The Trump administration’s cancellation of $766 million in contracts to develop mRNA vaccines against potential pandemic flu ...
The S&P 500 added 1% on Friday, June 6, as a strong jobs report pointed to resilience in the labor market despite ...
CURE spoke with the principal investigator of a clinical trial evaluating a therapeutic vaccine for patients with advanced ...
The Trump administration’s cancellation of $766 million in contracts to develop mRNA vaccines against potential pandemic flu viruses is the latest blow to national defense, former health security ...
23h
Zacks Investment Research on MSNWhy Is Mirum Pharmaceuticals (MIRM) Down 1.3% Since Last Earnings Report?It has been about a month since the last earnings report for Mirum Pharmaceuticals, Inc. (MIRM). Shares have lost about 1.3% in that time frame, underperforming the S&P 500. Will the recent negative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results